India vs Indonesia: New or unknown treatment history cases: Pulmonary, bacteriologically
India
1.01 million
in 2023
Indonesia
376,117
in 2023
India rank
1st
Indonesia rank
2nd
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- India
- Indonesia
How they compare
India currently reports 1.01 million against 376,117 in Indonesia, a difference of 637,733.
That makes India's figure about 2.7 times Indonesia's.
Across all 11 years both countries report, India has been ahead every year.
India ranks 1st and Indonesia ranks 2nd of 197 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 783,287 | 205,135 | 578,152 | India |
| 2020s | 866,264 | 277,264 | 589,001 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, India or Indonesia?
- India, at 1.01 million against 376,117 in Indonesia as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between India and Indonesia?
- 637,733, with India ahead.
- How many years of comparable data are there for India and Indonesia?
- 11 years are reported by both, from 2013 to 2023.
- How do India and Indonesia rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- India ranks 1st and Indonesia ranks 2nd of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.